Genesis Molecular AI

About Genesis Molecular AI

Genesis Molecular AI develops and deploys GEMS, an AI operating system for drug discovery that integrates proprietary AI and physics research to find potent, selective drug candidates against challenging protein targets. Their platform leverages advanced models such as Pearl, a 3D diffusion foundation model, to accelerate structure-based drug design and medicinal chemistry workflows. The company operates in the biotech/pharmaceutical space, offering front-line computational methods and engineering support to pharma partners for rapid target exploration and medicine development. Headquartered with a global research and development focus, Genesis positions itself at the intersection of molecular science and artificial intelligence to enable scalable discovery.